PATENT CLAIM ANALYSIS

Application Number: 16084308
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "495000"]

Abstract:
A prolonged release multiple unit dosage form, preferably pellets, of cysteamine, cystamine or a pharmaceutically acceptable salt thereof, preferably cysteamine bitartrate, with a non gastro-resistant coating is described. The dosage form is particularly indicated for the administration to patients once or twice a day and it can be used also for pediatric administration.

Claim (Index 3):
The dosage form according to  claim 1 , wherein the multiple units are pellets.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.33333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15238037', '12835863', '13126236', '11669630', '15172955']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.707001358031196
- 35 USC 102 Novelty (BERT): 0.4885451841394366
- Combined Prediction Score: 0.68515574064202
- Mean Citation Score: 172.02167
- Max Citation Score: 176.6465
- Similarity Product: 119.10607276833058

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test